Quantitative Vector Screening to Improve Sensing and Reduce Inappropriate Shocks With the Subcutaneous Implantable Cardioverter Defibrillator.

IF 9.8 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS
Thomas A Boyle, David C Callans, Rajat Deo, Sanjay Dixit, Andres Enriquez, Andrew E Epstein, Fermin Garcia, Gustavo Guandalini, Balaram K Hanumanthu, Matthew C Hyman, Ramanan Kumareswaran, David Lin, Francis E Marchlinski, Timothy M Markman, Maiwand Mirwais, Saman Nazarian, Michael Riley, Vincent See, Poojita Shivamurthy, Gregory E Supple, Robert Schaller, David S Frankel
{"title":"Quantitative Vector Screening to Improve Sensing and Reduce Inappropriate Shocks With the Subcutaneous Implantable Cardioverter Defibrillator.","authors":"Thomas A Boyle, David C Callans, Rajat Deo, Sanjay Dixit, Andres Enriquez, Andrew E Epstein, Fermin Garcia, Gustavo Guandalini, Balaram K Hanumanthu, Matthew C Hyman, Ramanan Kumareswaran, David Lin, Francis E Marchlinski, Timothy M Markman, Maiwand Mirwais, Saman Nazarian, Michael Riley, Vincent See, Poojita Shivamurthy, Gregory E Supple, Robert Schaller, David S Frankel","doi":"10.1161/CIRCEP.125.014581","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The subcutaneous Implantable Cardioverter Defibrillator (S-ICD) offers protection from sudden cardiac death without transvenous leads. Although contemporary techniques and programming have reduced inappropriate shocks, high rates persist in certain populations. The objective of this study was to evaluate the impact of a novel quantitative vector screening (QVS) protocol on the incidence of sensing-related complications and inappropriate shocks in patients undergoing S-ICD implantation.</p><p><strong>Methods: </strong>We analyzed 223 consecutive patients who underwent S-ICD implantation at the Hospital of the University of Pennsylvania from December 2018 to July 2025. Traditional vector screening was used before 2023. In 2023, we implemented QVS, which incorporated quantitative sensing scores for each candidate and raised the threshold for S-ICD implantation. The primary end point was time to first inappropriate shock or under-sensed ventricular arrhythmia. Secondary outcomes included SMART Pass deactivation and need for device revision. Outcomes were reported as survival analyses.</p><p><strong>Results: </strong>During preimplant screening, the QVS protocol reduced patient eligibility from 96% to 83%. The median follow-up after implant was 42 months (interquartile range, 48) in the traditional vector screening arm and 18 months (interquartile range, 15) in the QVS arm. The primary end point of time to first inappropriate shock or under-sensed ventricular arrhythmia was longer in the QVS arm (log-rank, <i>P</i>=0.02). There were 23 primary end point events among 145 patients in the traditional vector screening arm (5.2 per 100 patient-years [95% CI, 3.1-7.4]) and 2 primary end point events among 78 patients in the QVS arm (1.8 per 100 patient-years [95% CI, 0.01-4.38]).</p><p><strong>Conclusions: </strong>Implementation of a novel S-ICD screening protocol with stricter eligibility thresholds reduced sensing-related complications, particularly inappropriate shocks.</p>","PeriodicalId":10319,"journal":{"name":"Circulation. Arrhythmia and electrophysiology","volume":" ","pages":"e014581"},"PeriodicalIF":9.8000,"publicationDate":"2026-04-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Circulation. Arrhythmia and electrophysiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1161/CIRCEP.125.014581","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The subcutaneous Implantable Cardioverter Defibrillator (S-ICD) offers protection from sudden cardiac death without transvenous leads. Although contemporary techniques and programming have reduced inappropriate shocks, high rates persist in certain populations. The objective of this study was to evaluate the impact of a novel quantitative vector screening (QVS) protocol on the incidence of sensing-related complications and inappropriate shocks in patients undergoing S-ICD implantation.

Methods: We analyzed 223 consecutive patients who underwent S-ICD implantation at the Hospital of the University of Pennsylvania from December 2018 to July 2025. Traditional vector screening was used before 2023. In 2023, we implemented QVS, which incorporated quantitative sensing scores for each candidate and raised the threshold for S-ICD implantation. The primary end point was time to first inappropriate shock or under-sensed ventricular arrhythmia. Secondary outcomes included SMART Pass deactivation and need for device revision. Outcomes were reported as survival analyses.

Results: During preimplant screening, the QVS protocol reduced patient eligibility from 96% to 83%. The median follow-up after implant was 42 months (interquartile range, 48) in the traditional vector screening arm and 18 months (interquartile range, 15) in the QVS arm. The primary end point of time to first inappropriate shock or under-sensed ventricular arrhythmia was longer in the QVS arm (log-rank, P=0.02). There were 23 primary end point events among 145 patients in the traditional vector screening arm (5.2 per 100 patient-years [95% CI, 3.1-7.4]) and 2 primary end point events among 78 patients in the QVS arm (1.8 per 100 patient-years [95% CI, 0.01-4.38]).

Conclusions: Implementation of a novel S-ICD screening protocol with stricter eligibility thresholds reduced sensing-related complications, particularly inappropriate shocks.

定量载体筛选提高感应和减少不适当的电击与皮下植入式心律转复除颤器。
背景:皮下植入式心律转复除颤器(S-ICD)可以在没有经静脉导联的情况下保护心脏性猝死。虽然现代技术和编程已经减少了不适当的电击,但在某些人群中仍然存在高发生率。本研究的目的是评估一种新的定量载体筛选(QVS)方案对S-ICD植入患者的感觉相关并发症和不适当电击发生率的影响。方法:我们分析了2018年12月至2025年7月在宾夕法尼亚大学医院连续接受S-ICD植入的223例患者。2023年之前使用了传统的媒介筛查。2023年,我们实施了QVS,将每个候选的定量感知评分纳入其中,提高了S-ICD植入的门槛。主要终点是首次发生不适当休克或感觉不足的室性心律失常的时间。次要结局包括SMART Pass停用和器械修改需求。结果以生存分析报告。结果:在植入前筛选期间,QVS方案将患者的资格从96%降低到83%。植入后中位随访时间,传统载体筛选组为42个月(四分位数范围48),QVS组为18个月(四分位数范围15)。在QVS组中,首次不适当休克或感觉不足的室性心律失常的主要终点时间更长(log-rank, P=0.02)。145例传统载体筛查组患者中有23例主要终点事件(5.2例/ 100患者-年[95% CI, 3.1-7.4]), 78例QVS组患者中有2例主要终点事件(1.8例/ 100患者-年[95% CI, 0.01-4.38])。结论:实施具有更严格资格阈值的新型S-ICD筛查方案减少了与感觉相关的并发症,特别是不适当的电击。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
13.70
自引率
4.80%
发文量
187
审稿时长
4-8 weeks
期刊介绍: Circulation: Arrhythmia and Electrophysiology is a journal dedicated to the study and application of clinical cardiac electrophysiology. It covers a wide range of topics including the diagnosis and treatment of cardiac arrhythmias, as well as research in this field. The journal accepts various types of studies, including observational research, clinical trials, epidemiological studies, and advancements in translational research.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书